{ "resourceType":"Bundle", "id": "suliqua-gravitate", "identifier": { "system": "https://www.gravitatehealth.eu/sid/doc", "value": "EU/1/16/1157/003" }, "type": "document", "timestamp": "2017-06-23T08:38:00+02:00", "entry": [{ "resource": { "resourceType":"Composition", "id": "cfsb1316794754115", "language": "no", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb1316794754115\" (Language \"no\")

: final\n status

: Package Leaflet \n type (#100000155538)

: 2015-02-07T13:28:17Z\n date

: \n authorSee above (Organization/cfsb6005885654359)

: TEST PURPOSES ONLY - Suliqua Vulcan ePI\n title

: unrestricted\n confidentiality

" }, "status": "final", "type": { "coding": [{ "system": "https://spor.ema.europa.eu/", "code": "100000155538" }], "text": "Package Leaflet" }, "date": "2015-02-07T13:28:17Z", "author": [{ "reference": "Organization/cfsb6005885654359" }], "title": "TEST PURPOSES ONLY - Suliqua Vulcan ePI", "section": [{ "title": "B. PAKNINGSVEDLEGG", "code": { "coding": [{ "system": "https://spor.ema.europa.eu/", "code": "100000155538" }], "text": "B. PAKNINGSVEDLEGG" }, "text": { "status": "additional", "div": "

Pakningsvedlegg: Informasjon til brukeren

" } }, { "title": "1. Hva Suliqua er og hva det brukes mot", "code": { "coding": [{ "system": "https://spor.ema.europa.eu/", "code": "100000155538-1" }], "text": "B. PAKNINGSVEDLEGG" }, "text": { "status": "additional", "div": "
1. Hva Suliqua er og hva det brukes mot
" } }, { "title": "2. Hva du må vite før du bruker Suliqua", "code": { "coding": [{ "system": "https://spor.ema.europa.eu/", "code": "100000155538-2" }], "text": "B. PAKNINGSVEDLEGG" }, "text": { "status": "additional", "div": "
2. Hva du må vite før du bruker Suliqua
" } }, { "title": "3. Hvordan du bruker Suliqua", "code": { "coding": [{ "system": "https://spor.ema.europa.eu/", "code": "100000155538-3" }], "text": "B. PAKNINGSVEDLEGG" }, "text": { "status": "additional", "div": "
3. Hvordan du bruker Suliqua
" } }, { "title": "4. Mulige bivirkninger", "code": { "coding": [{ "system": "https://spor.ema.europa.eu/", "code": "100000155538-4" }], "text": "B. PAKNINGSVEDLEGG" }, "text": { "status": "additional", "div": "
4. Mulige bivirkninger
" } }, { "title": "5. Hvordan du oppbevarer Suliqua", "code": { "coding": [{ "system": "https://spor.ema.europa.eu/", "code": "100000155538-2" }], "text": "B. PAKNINGSVEDLEGG" }, "text": { "status": "additional", "div": "
5. Hvordan du oppbevarer Suliqua
" } }, { "title": "6. Innholdet i pakningen og ytterligere informasjon", "code": { "coding": [{ "system": "https://spor.ema.europa.eu/", "code": "100000155538-2" }], "text": "B. PAKNINGSVEDLEGG" }, "text": { "status": "additional", "div": "
6. Innholdet i pakningen og ytterligere informasjon
" } }] } }, { "resource": { "resourceType":"Organization", "id": "cfsb6005885654359", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb6005885654359\"

: id: ORG-100000789 (OFFICIAL)\n identifier

: true\n active

: Marketing authorisation holder \n type (#/#bus)

: Sanofi-Aventis Groupe\n name

: 54 Rue La Boetie Paris 75008 France(WORK)\n address

" }, "identifier": [{ "use": "official", "system": "https://spor.ema.europa.eu/rmswi/#/", "value": "ORG-100000789" }], "active": true, "type": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "bus" }], "text": "Marketing authorisation holder" }, "name": "Sanofi-Aventis Groupe", "contact": [{ "address": { "use": "work", "type": "physical", "text": "54 Rue La Boetie Paris 75008 France", "line":[ "54 Rue La Boetie" ], "city": "Paris", "country": "fr" } }] } }, { "resource": { "resourceType":"Organization", "id": "cfsb2176224411725", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb2176224411725\"

: id: ORG-100001175 (OFFICIAL)\n identifier

: true\n active

: Manufacturer API \n type (#/#220000000033)

: Sanofi-Aventis Deutschland GmbH\n name

: Brueningstrasse 50, Industriepark Höchst, 65926 Frankfurt am Main, GERMANY(WORK)\n address

" }, "identifier": [{ "use": "official", "system": "https://spor.ema.europa.eu/omswi/#/", "value": "ORG-100001175" }], "active": true, "type": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "220000000033" }], "text": "Manufacturer API" }, "name": "Sanofi-Aventis Deutschland GmbH", "contact": [{ "address": { "use": "work", "type": "physical", "text": "Brueningstrasse 50, Industriepark Höchst, 65926 Frankfurt am Main, GERMANY", "line":[ "Brueningstrasse 50, Industriepark Höchst" ], "city": "Frankfurt am Main", "postalCode": "65926", "country": "de" } }] } }, { "resource": { "resourceType":"Organization", "id": "cfsb7719260512249", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb7719260512249\"

: id: ORG-100001175 (OFFICIAL)\n identifier

: true\n active

: Manufacturer Batch release \n type (#/#220000000033)

: Sanofi-Aventis Deutschland GmbH\n name

: Brueningstrasse 50, Industriepark Höchst, 65926 Frankfurt am Main, GERMANY(WORK)\n address

" }, "identifier": [{ "use": "official", "system": "https://spor.ema.europa.eu/omswi/#/", "value": "ORG-100001175" }], "active": true, "type": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "220000000033" }], "text": "Manufacturer Batch release" }, "name": "Sanofi-Aventis Deutschland GmbH", "contact": [{ "address": { "use": "work", "type": "physical", "text": "Brueningstrasse 50, Industriepark Höchst, 65926 Frankfurt am Main, GERMANY", "line":[ "Brueningstrasse 50, Industriepark Höchst" ], "city": "Frankfurt am Main", "postalCode": "65926", "country": "de" } }] } }, { "resource": { "resourceType":"Organization", "id": "cfsb1639015880655", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb1639015880655\"

: id: ORG-100013412 (OFFICIAL)\n identifier

: true\n active

: Medicines Regulatory Authority \n type (#/#220000000033)

: European Medicines Agency\n name

: Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands(WORK)\n address

" }, "identifier": [{ "use": "official", "system": "https://spor.ema.europa.eu/omswi/#/", "value": "ORG-100013412" }], "active": true, "type": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "220000000033" }], "text": "Medicines Regulatory Authority" }, "name": "European Medicines Agency", "contact": [{ "address": { "use": "work", "type": "physical", "text": "Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands", "line":[ "Carretera De Martorell 41 61, Poligono Industrial Nord-Est" ], "city": "Amsterdam", "postalCode": "1083 HS", "country": "nl" } }] } }, { "resource": { "resourceType":"RegulatedAuthorization", "id": "cfsb2023900992766", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb2023900992766\"

: id: EU/1/16/1157/003 (OFFICIAL)\n identifier

: \n subjectSee above (MedicinalProductDefinition/cfsb7123030148537)

: Marketing Authorisation \n type (#/#100000072062)

: Suliqua 100 units/ml + 33 microgram/ml solution for injection in x3 pre-filled pens\n description

: European Union \n region (unknown#eu)

: Active \n status (\n PublicationStatus

: 2017-01-11T13:28:17Z\n statusDate

: 2017-01-11T13:28:17Z --> (ongoing)\n validityPeriod

: \n holderSee above (Organization/cfsb6005885654359)

: \n regulatorSee above (Organization/cfsb1639015880655)

" }, "identifier": [{ "use": "official", "system": "https://spor.ema.europa.eu/rmswi/#/", "value": "EU/1/16/1157/003" }], "subject": { "reference": "MedicinalProductDefinition/cfsb7123030148537" }, "type": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "100000072062" }], "text": "Marketing Authorisation" }, "description": "Suliqua 100 units/ml + 33 microgram/ml solution for injection in x3 pre-filled pens", "region": [{ "coding": [{ "system": "urn:iso:std:iso:3166", "code": "eu" }], "text": "European Union" }], "status": { "coding": [{ "system": "http://hl7.org/fhir/publication-status", "code": "active" }], "text": "Active" }, "statusDate": "2017-01-11T13:28:17Z", "validityPeriod": { "start": "2017-01-11T13:28:17Z" }, "holder": { "reference": "Organization/cfsb6005885654359" }, "regulator": { "reference": "Organization/cfsb1639015880655" } } }, { "resource": { "resourceType":"MedicinalProductDefinition", "id": "cfsb7123030148537", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb7123030148537\"

: id: EU/1/16/1157/003 (OFFICIAL)\n identifier

: Marketing Authorisation \n type (#/#100000072062)

: Human use \n domain (#/#100000000012)

: 1\n version

: Active \n status (\n PublicationStatus

: 2015-02-07T13:28:17Z\n statusDate

: Suliqua 100 units/ml + 33 microgram/ml solution for injection in a pre-filled pen:\nEach pre-filled pen contains 300 units of insulin glargine and 100 micrograms lixisenatide in 3 ml solution.\nEach ml contains 100 units of insulin glargine and 33 micrograms lixisenatide.\nEach dose step contains 1 unit of insulin glargine and 0.33 micrograms of lixisenatide\n description

: Subcutaneous use \n route (#/#100000073633)

: Suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without SGLT-2 inhibitors.\n indication

: Medicinal product subject to medical prescription \n legalStatusOfSupply (#/#100000072084)

: insulin glargine and lixisenatide \n classification (#A10AE54) (#/#100000019249)

name

: Suliqua 100 units/ml + 33 micrograms/ml solution for injection in a pre-filled pen\n productName

: Full name \n type (#/#220000000001)

NameParts

-PartType
*Solution for injectionPharmaceutical dose form part \n (#/#220000000005)

CountryLanguages

-CountryJurisdictionLanguage
*European Union \n (unknown#eu)European Union \n (unknown#eu)English \n (\n Tags for the Identification of Languages
" }, "identifier": [{ "use": "official", "system": "https://spor.ema.europa.eu/pmswi/#/", "value": "EU/1/16/1157/003" }], "type": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "100000072062" }], "text": "Marketing Authorisation" }, "domain": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "100000000012" }], "text": "Human use" }, "version": "1", "status": { "coding": [{ "system": "http://hl7.org/fhir/publication-status", "code": "active", "display": "Active" }] }, "statusDate": "2015-02-07T13:28:17Z", "description": "Suliqua 100 units/ml + 33 microgram/ml solution for injection in a pre-filled pen:\nEach pre-filled pen contains 300 units of insulin glargine and 100 micrograms lixisenatide in 3 ml solution.\nEach ml contains 100 units of insulin glargine and 33 micrograms lixisenatide.\nEach dose step contains 1 unit of insulin glargine and 0.33 micrograms of lixisenatide", "route": [{ "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "100000073633" }], "text": "Subcutaneous use" }], "indication": "Suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without SGLT-2 inhibitors.", "legalStatusOfSupply": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "100000072084" }], "text": "Medicinal product subject to medical prescription" }, "classification": [{ "coding": [{ "system": "http://www.whocc.no/atc", "code": "A10AE54" }], "text": "insulin glargine and lixisenatide" }, { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "100000019249" }], "text": "Diabetes mellitus inadequate control" }], "name": [{ "productName": "Suliqua 100 units/ml + 33 micrograms/ml solution for injection in a pre-filled pen", "type": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "220000000001" }], "text": "Full name" }, "part": [{ "part": "Solution for injection", "type": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "220000000005" }], "text": "Pharmaceutical dose form part" } }], "usage": [{ "country": { "coding": [{ "system": "urn:iso:std:iso:3166", "code": "eu" }], "text": "European Union" }, "jurisdiction": { "coding": [{ "system": "urn:iso:std:iso:3166", "code": "eu" }], "text": "European Union" }, "language": { "coding": [{ "system": "urn:ietf:bcp:47", "code": "en" }], "text": "English" } }] }] } }, { "resource": { "resourceType":"PackagedProductDefinition", "id": "cfsb5595996591065", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb5595996591065\"

: id: EU/1/16/1157/003 (OFFICIAL)\n identifier

: 3 ml cartridge (glass) in a pre-filled pen\n name

: Chemical Medicinal Product \n type (#/#100000155527)

: Active \n status (\n PublicationStatus

: 2015-02-07T13:28:17Z\n statusDate

: 3 ml\n containedItemQuantity

: Type I colourless glass cartridge with a black plunger (bromobutyl rubber) and a flanged cap (aluminium) with inserted laminated sealing disks (bromobutyl rubber on the medicinal product side and polyisoprene on the outside) containing 3 ml of solution. Each cartridge is assembled into a disposable pen.\n description

: false\n copackagedIndicator

: \n manufacturerSee above (Organization/cfsb2176224411725)

Packages

-IdentifierTypeQuantityMaterial
*id: EU/1/16/1157/003 (OFFICIAL)Pre-filled pen \n (#/#100000073543)3Glass type I \n (#/#200000003204)
" }, "identifier": [{ "use": "official", "system": "https://spor.ema.europa.eu/pmswi/#/", "value": "EU/1/16/1157/003" }], "name": "3 ml cartridge (glass) in a pre-filled pen", "type": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "100000155527" }], "text": "Chemical Medicinal Product" }, "packageFor": [{ "reference": "MedicinalProductDefinition/cfsb7123030148537" }], "status": { "coding": [{ "system": "http://hl7.org/fhir/publication-status", "code": "active", "display": "Active" }] }, "statusDate": "2015-02-07T13:28:17Z", "containedItemQuantity": { "value": 3, "unit": "ml" }, "description": "Type I colourless glass cartridge with a black plunger (bromobutyl rubber) and a flanged cap (aluminium) with inserted laminated sealing disks (bromobutyl rubber on the medicinal product side and polyisoprene on the outside) containing 3 ml of solution. Each cartridge is assembled into a disposable pen.", "copackagedIndicator": false, "manufacturer": [{ "reference": "Organization/cfsb2176224411725" }], "packaging": { "identifier": { "use": "official", "system": "https://spor.ema.europa.eu/rmswi/#/", "value": "EU/1/16/1157/003" }, "type": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "100000073543" }], "text": "Pre-filled pen" }, "quantity": "3", "material": [{ "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "200000003204" }], "text": "Glass type I" }] } } }, { "resource": { "resourceType":"AdministrableProductDefinition", "id": "cfsb5880516529064", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb5880516529064\"

: id: TBD (OFFICIAL)\n identifier

: active\n status

: \n formOfSee above (MedicinalProductDefinition/cfsb7123030148537)

: Solution for injection \n administrableDoseForm (#100000073863)

: Pen \n unitOfPresentation (#/#200000002135)

: \n producedFromSee above (ManufacturedItemDefinition/cfsb7089233601948)

routeOfAdministration

: Subcutaneous use \n code (#100000073633)

TargetSpecies

-Code
*Human \n (#/#100000109093)
" }, "identifier": [{ "use": "official", "system": "https://spor.ema.europa.eu/pmswi/", "value": "TBD" }], "status": "active", "formOf": [{ "reference": "MedicinalProductDefinition/cfsb7123030148537" }], "administrableDoseForm": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "100000073863" }], "text": "Solution for injection" }, "unitOfPresentation": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "200000002135" }], "text": "Pen" }, "producedFrom": [{ "reference": "ManufacturedItemDefinition/cfsb7089233601948" }], "routeOfAdministration": [{ "code": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "100000073633" }], "text": "Subcutaneous use" }, "targetSpecies": [{ "code": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "100000109093" }], "text": "Human" } }] }] } }, { "resource": { "resourceType":"ManufacturedItemDefinition", "id": "cfsb7089233601948", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb7089233601948\"

: id: EU/1/16/1157/003 (OFFICIAL)\n identifier

: active\n status

: Solution \n manufacturedDoseForm (#/#200000002007)

: Pen \n unitOfPresentation (#/#200000002135)

: \n manufacturerSee above (Organization/cfsb2176224411725)

" }, "identifier": [{ "use": "official", "system": "https://spor.ema.europa.eu/pmswi/#/", "value": "EU/1/16/1157/003" }], "status": "active", "manufacturedDoseForm": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "200000002007" }], "text": "Solution" }, "unitOfPresentation": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "200000002135" }], "text": "Pen" }, "manufacturer": [{ "reference": "Organization/cfsb2176224411725" }] } }, { "resource": { "resourceType":"Ingredient", "id": "cfsb3768802370375", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb3768802370375\"

: id: 2ZM8CX04RZ (OFFICIAL)\n identifier

: active\n status

: active \n role (#/#00000072072)

: false\n allergenicIndicator

Manufacturers

-Manufacturer
*See above (Organization/cfsb2176224411725)

substance

Strengths

-Presentation[x]Basis
*100 units/mlactive ingredient - basis of strength \n (v3-RoleClassIngredientEntity#ACTIB)
" }, "identifier": { "use": "official", "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/", "value": "2ZM8CX04RZ" }, "status": "active", "role": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "00000072072" }], "text": "active" }, "allergenicIndicator": false, "manufacturer": [{ "manufacturer": { "reference": "Organization/cfsb2176224411725" } }], "substance": { "code": { "concept": { "coding": [{ "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/", "code": "2ZM8CX04RZ", "display": "Insulin glargine" }] } }, "strength": [{ "presentationQuantity": { "value": 100, "unit": "units/ml" }, "basis": { "coding": [{ "system": "http://terminology.hl7.org/ValueSet/v3-RoleClassIngredientEntity", "code": "ACTIB" }], "text": "active ingredient - basis of strength" } }] } } }, { "resource": { "resourceType":"Ingredient", "id": "cfsb8724428384435", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb8724428384435\"

: id: 74O62BB01U (OFFICIAL)\n identifier

: active\n status

: active \n role (#/#00000072072)

: false\n allergenicIndicator

Manufacturers

-Manufacturer
*See above (Organization/cfsb2176224411725)

substance

Strengths

-Presentation[x]Basis
*50 ug/mlactive ingredient - basis of strength \n (v3-RoleClassIngredientEntity#ACTIB)
" }, "identifier": { "use": "official", "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/", "value": "74O62BB01U" }, "status": "active", "role": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "00000072072" }], "text": "active" }, "allergenicIndicator": false, "manufacturer": [{ "manufacturer": { "reference": "Organization/cfsb2176224411725" } }], "substance": { "code": { "concept": { "coding": [{ "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/", "code": "74O62BB01U", "display": "Lixisenatide" }] } }, "strength": [{ "presentationQuantity": { "value": 50, "unit": "ug/ml" }, "basis": { "coding": [{ "system": "http://terminology.hl7.org/ValueSet/v3-RoleClassIngredientEntity", "code": "ACTIB" }], "text": "active ingredient - basis of strength" } }] } } }, { "resource": { "resourceType":"Ingredient", "id": "cfsb8364716455502", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb8364716455502\"

: id: 74O62BB01U (OFFICIAL)\n identifier

: active\n status

: active \n role (#/#00000072072)

: false\n allergenicIndicator

Manufacturers

-Manufacturer
*See above (Organization/cfsb2176224411725)

substance

Strengths

-Presentation[x]Basis
*33 ug/mlactive ingredient - basis of strength \n (v3-RoleClassIngredientEntity#ACTIB)
" }, "identifier": { "use": "official", "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/", "value": "74O62BB01U" }, "status": "active", "role": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "00000072072" }], "text": "active" }, "allergenicIndicator": false, "manufacturer": [{ "manufacturer": { "reference": "Organization/cfsb2176224411725" } }], "substance": { "code": { "concept": { "coding": [{ "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/", "code": "74O62BB01U", "display": "Lixisenatide" }] } }, "strength": [{ "presentationQuantity": { "value": 33, "unit": "ug/ml" }, "basis": { "coding": [{ "system": "http://terminology.hl7.org/ValueSet/v3-RoleClassIngredientEntity", "code": "ACTIB" }], "text": "active ingredient - basis of strength" } }] } } }, { "resource": { "resourceType":"Ingredient", "id": "cfsb7644964356957", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb7644964356957\"

: id: PDC6A3C0OX (OFFICIAL)\n identifier

: active\n status

: Excipient \n role (#/#100000072082)

: false\n allergenicIndicator

Manufacturers

-Manufacturer
*See above (Organization/cfsb2176224411725)

substance

" }, "identifier": { "use": "official", "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/", "value": "PDC6A3C0OX" }, "status": "active", "role": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "100000072082" }], "text": "Excipient" }, "allergenicIndicator": false, "manufacturer": [{ "manufacturer": { "reference": "Organization/cfsb2176224411725" } }], "substance": { "code": { "concept": { "coding": [{ "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/", "code": "PDC6A3C0OX", "display": "Glycerol" }] } } } } }, { "resource": { "resourceType":"Ingredient", "id": "cfsb8873568628101", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb8873568628101\"

: id: AE28F7PNPL (OFFICIAL)\n identifier

: active\n status

: Excipient \n role (#/#100000072082)

: false\n allergenicIndicator

Manufacturers

-Manufacturer
*See above (Organization/cfsb2176224411725)

substance

" }, "identifier": { "use": "official", "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/", "value": "AE28F7PNPL" }, "status": "active", "role": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "100000072082" }], "text": "Excipient" }, "allergenicIndicator": false, "manufacturer": [{ "manufacturer": { "reference": "Organization/cfsb2176224411725" } }], "substance": { "code": { "concept": { "coding": [{ "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/", "code": "AE28F7PNPL", "display": "Methionine" }] } } } } }, { "resource": { "resourceType":"Ingredient", "id": "cfsb7194634205639", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb7194634205639\"

: id: GGO4Y809LO (OFFICIAL)\n identifier

: active\n status

: Excipient \n role (#/#100000072082)

: false\n allergenicIndicator

Manufacturers

-Manufacturer
*See above (Organization/cfsb2176224411725)

substance

" }, "identifier": { "use": "official", "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/", "value": "GGO4Y809LO" }, "status": "active", "role": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "100000072082" }], "text": "Excipient" }, "allergenicIndicator": false, "manufacturer": [{ "manufacturer": { "reference": "Organization/cfsb2176224411725" } }], "substance": { "code": { "concept": { "coding": [{ "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/", "code": "GGO4Y809LO", "display": "Metacresol" }] } } } } }, { "resource": { "resourceType":"Ingredient", "id": "cfsb9561966749493", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb9561966749493\"

: id: 86Q357L16B (OFFICIAL)\n identifier

: active\n status

: Excipient \n role (#/#100000072082)

: false\n allergenicIndicator

Manufacturers

-Manufacturer
*See above (Organization/cfsb2176224411725)

substance

" }, "identifier": { "use": "official", "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/", "value": "86Q357L16B" }, "status": "active", "role": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "100000072082" }], "text": "Excipient" }, "allergenicIndicator": false, "manufacturer": [{ "manufacturer": { "reference": "Organization/cfsb2176224411725" } }], "substance": { "code": { "concept": { "coding": [{ "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/", "code": "86Q357L16B", "display": "Zinc chloride" }] } } } } }, { "resource": { "resourceType":"Ingredient", "id": "cfsb1268193754623", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb1268193754623\"

: id: QTT17582CB (OFFICIAL)\n identifier

: active\n status

: Excipient \n role (#/#100000072082)

: false\n allergenicIndicator

Manufacturers

-Manufacturer
*See above (Organization/cfsb2176224411725)

substance

" }, "identifier": { "use": "official", "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/", "value": "QTT17582CB" }, "status": "active", "role": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "100000072082" }], "text": "Excipient" }, "allergenicIndicator": false, "manufacturer": [{ "manufacturer": { "reference": "Organization/cfsb2176224411725" } }], "substance": { "code": { "concept": { "coding": [{ "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/", "code": "QTT17582CB", "display": "Concentrated hydrochloric acid" }] } } } } }, { "resource": { "resourceType":"Ingredient", "id": "cfsb3286639616821", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb3286639616821\"

: id: 55X04QC32I (OFFICIAL)\n identifier

: active\n status

: Excipient \n role (#/#100000072082)

: false\n allergenicIndicator

Manufacturers

-Manufacturer
*See above (Organization/cfsb2176224411725)

substance

" }, "identifier": { "use": "official", "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/", "value": "55X04QC32I" }, "status": "active", "role": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "100000072082" }], "text": "Excipient" }, "allergenicIndicator": false, "manufacturer": [{ "manufacturer": { "reference": "Organization/cfsb2176224411725" } }], "substance": { "code": { "concept": { "coding": [{ "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/", "code": "55X04QC32I", "display": "Sodium hydroxide" }] } } } } }, { "resource": { "resourceType":"Ingredient", "id": "cfsb7034777237464", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb7034777237464\"

: id: 059QF0KO0R (OFFICIAL)\n identifier

: active\n status

: Excipient \n role (#/#100000072082)

: false\n allergenicIndicator

Manufacturers

-Manufacturer
*See above (Organization/cfsb2176224411725)

substance

" }, "identifier": { "use": "official", "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/", "value": "059QF0KO0R" }, "status": "active", "role": { "coding": [{ "system": "https://spor.ema.europa.eu/rmswi/", "code": "100000072082" }], "text": "Excipient" }, "allergenicIndicator": false, "manufacturer": [{ "manufacturer": { "reference": "Organization/cfsb2176224411725" } }], "substance": { "code": { "concept": { "coding": [{ "system": "https://gsrs.ncats.nih.gov/ginas/app/beta/", "code": "059QF0KO0R", "display": "Water for injections" }] } } } } }, { "resource": { "resourceType":"ClinicalUseDefinition", "id": "cfsb4325643431772", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb4325643431772\"

: id: Hypersensitivity reaction (OFFICIAL)\n identifier

: contraindication\n type

: \n subject

" }, "identifier": [{ "use": "official", "system": "https://spor.ema.europa.eu/rmswi/#/", "value": "Hypersensitivity reaction" }], "type": "contraindication", "subject": [{ "reference": "MedicinalProductDefinition/cfsb1151803027115" }, { "reference": "MedicinalProductDefinition/cfsb7123030148537" }] } }, { "resource": { "resourceType":"ClinicalUseDefinition", "id": "cfsb8699684597483", "text": { "status": "generated", "div": "

Generated Narrative

Resource \"cfsb8699684597483\"

: id: Type 2 diabetes mellitus (OFFICIAL)\n identifier

: indication\n type

: \n subject

" }, "identifier": [{ "use": "official", "system": "https://spor.ema.europa.eu/rmswi/#/", "value": "Type 2 diabetes mellitus" }], "type": "indication", "subject": [{ "reference": "MedicinalProductDefinition/cfsb1151803027115" }, { "reference": "MedicinalProductDefinition/cfsb7123030148537" }] } }, { "resource": { "resourceType":"DocumentReference", "id": "cfsb5671063821622", "text": { "status": "additional", "div": "
" }, "status": "current", "description": "Instruksjonsfilm for bruk av ferdigfylt penn.", "content": [{ "attachment": { "contentType": "video/mp4", "language": "no", "url": "https://www.felleskatalogen.no/medisin/film/suliqua-ferdigfylt-penn.mp4", "title": "Suliqua ferdigfylt penn", "creation": "2018-09-28", "height": "404", "width": "720", "duration": "366" } }] } }] }